CanSino Biologics, Inc.SSE: 688185

Announcement on Convening the Q3 2024 Performance Briefing

Nov 16, 2024 · Issued by CanSino Biologics, Inc. via Shanghai Stock Exchange

Filed with SSE · Nov 16, 2024

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-424

Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

CanSino Biologics, Inc. on 6ix

Earlier from CanSino Biologics

Report for Q3 2024Oct 30, 2024
Voluntary Disclosure on the Approval of Clinical Trial for Recombinant Polio Vaccine in IndonesiaOct 10, 2024
Announcement on Participating in the 2024 Semi-Annual Collective Performance Briefing for Pharmaceutical and Biological ProductsSep 7, 2024
Announcement on Resolutions of the 4th Meeting of the 3rd Board of SupervisorsAug 30, 2024
Announcement on Participating in the 2024 Tianjin Region Listed Companies' Semi-Annual Performance Briefing and Online Collective Reception Day EventAug 28, 2024

Later from CanSino Biologics

Announcement on Resolution of the 2nd Holders' Meeting of 2023 Employee A-share Ownership PlanNov 26, 2024
Announcement on the Voluntary Disclosure of the Acceptance of the Supplemental Drug Application for the Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)Nov 27, 2024
Indicative Announcement on One of Actual Controllers Adjusting H-share Holding Method and Signing Supplementary Agreement (II) to Concerted Action AgreementDec 5, 2024
Indicative Announcement on the Termination of Partial Shareholders' Concerted Action Relationship and Changes in EquityDec 14, 2024
Announcement of the Acceptance of the Drug Registration Application for the "Diphtheria, Tetanus and Acellular Pertussis (Component) Combined Vaccine, Adsorbed" for Infants and Young ChildrenDec 17, 2024

All CanSino Biologics news releases

Follow CanSino Biologics into a list and get an email when it puts out news.

Follow CanSino Biologics